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Emiliania huxleyi virus strain 86 is the largest algal virus sequenced to date and is unique among the Phycodna-
viridae since its genome is predicted to contain six RNA polymerase subunit genes. We have used a virus microarray
to profile the temporal transcription strategy of this unusual virus during infection. There are two distinct
transcription phases to the infection process. The primary phase is dominated by a group of coding sequences
(CDSs) expressed by 1 h postinfection that are localized to a subregion of the genome. The CDS of the primary
group have no database homologues, and each is associated with a unique promoter element. The remainder of the
CDSs are expressed in a secondary phase between 2 and 4 hours postinfection. Compartmentalized transcription
of the two distinctive phases is discussed. We hypothesize that immediately after infection the nucleic acid of the
virus targets the host nucleus, where primary-phase genes are transcribed by host RNA polymerase which recog-
nizes the viral promoter. Secondary-phase transcription may then be conducted in the cytoplasm.
Emiliania huxleyi virus strain 86, EhV-86, is the type species
of the genus Coccolithovirus within the family of algal viruses,
the Phycodnaviridae (14). EhV-86 is a large, double-stranded
DNA virus that infects the marine coccolithophorid Emiliania
huxleyi (13), a unicellular alga known for its elegant calcium
carbonate scales (coccoliths) that are produced intracellularly
and sequestered over its outer cell surface (21). E. huxleyi is
perhaps best known for its immense coastal and open-ocean
blooms at temperate latitudes and is a key species for current
studies on global biogeochemical cycles and climate modeling
(6, 19, 20).
We have previously sequenced the 407,339-bp genome of
EhV-86 and predicted that it encodes 472 protein coding se-
quences (CDSs) (22). This is the largest Phycodnaviridae ge-
nome sequenced to date. The functions of the 472 CDSs are
largely unknown: only 66 have been annotated with functional
product predictions on the basis of sequence similarity or pro-
tein domain matches (22). Genes of known function encode
DNA polymerase subunits, RNA polymerase subunits, sphin-
golipid biosynthesis enzymes, and eight proteases. The Phycod-
naviridae family was previously thought to lack RNA polymer-
ase; thus, the detection of six RNA polymerase subunits in
EhV-86 suggested a lifestyle distinct from those of other Phy-
codnaviridae (1–3, 22). A lytic–phase transcriptional profile
generated from E. huxleyi infected by EhV–86, 33 h postinfec-
tion, detected the presence of 65% of the predicted virus CDS
transcripts (22).
In many well-studied biological systems, viral transcripts are
commonly assigned into a kinetic class by their dependence on
protein synthesis or viral DNA replication (5). This is usually
achieved by monitoring the sensitivity of virus gene transcript
levels upon exposure to inhibitory drugs (5). Through the in-
hibition of translation or DNA replication with chemicals such
as cycloheximide and phosphonoacetic acid, transcripts can be
assigned into kinetic classes such as immediate-early (), early
(), early-late (1), and late (2). Kinetic stratification strongly
correlates with functional classification. Classically, immedi-
ate-early proteins perform regulatory functions; early proteins,
metabolic roles; and late proteins, structural and morphogenic
roles. The culturing conditions needed to sustain optimum
growth in tandem with the number of cells needed to extract
total RNA in useable quantities (experiments typically involve
tens of liters of culture medium) limit what can be done pres-
ently with the E. huxleyi experimental system. The application
of inhibiting drugs to E. huxleyi cultures is both impractical and
costly. Furthermore, the molecular biology of E. huxleyi is
almost as poorly understood as the molecular biology of its
virus, EhV-86. The use of drugs may have unknown affects on
both host and virus systems. To build on previous genome
sequencing work and to begin the task of characterizing all the
EhV-86 CDSs, the majority of which are of unknown function,
an expression profile of the first 4 h of infection was deter-
mined. We know from experience that mature virions are re-
leased from infected cells 4 h postinfection (data not shown);
hence, this initial period was profiled in detail. By exploiting a
synchronous infection and sampling early on, we avoided the
need for inhibitor drugs and profiled a natural infection cycle.
MATERIALS AND METHODS
Growth conditions and RNA extraction. Experimental methodology is de-
scribed in depth in the MIAME compliant database entry E-MAXD-8, available
at www.arrayexpress.com. Briefly, exponentially growing Emiliania huxleyi (1 
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106 cells ml1) was infected with EhV-86 (fresh lysate, 5  108 virions ml1) in
f/2 medium at 15°C in a Sanyo MLR-350 incubator with a ratio of 16:8 h of
light-dark illumination.
Total RNA was extracted 0, 1, 2, and 4 h postinfection, using a QIAGEN
midiprep kit, and used for microarray analysis as described previously (22).
Briefly, cell cultures (150 ml) were filtered (0.45-m Supor-200 membrane filter;
Pall Corporation), resuspended in 2 ml phosphate-buffered saline solution, pel-
leted by centrifugation (20,000  g, 1 min), resuspensed in 2 ml RNAlater
(QIAGEN), and stored at 20°C until processed with the QIAGEN midiprep kit.
As a control, virus particles were checked for the presence of RNA. The virus
particles were purified and concentrated as described previously (14). Briefly,
virus lysate (5 liters) was filtered (0.45-m Supor-200 membrane filter; Pall
Corporation), concentrated by a tangential flow ultrafiltration unit with a mo-
lecular weight cutoff of 50,000 (Vivaflow 50; Sartorius) to a final volume of 20 ml.
Aliquots (3.5 ml) of the concentrate were adjusted with CsCl to densities of 1.1,
1.2, 1.3, and 1.4, and gradients from 1.1 and 1.4 were created by ultracentrifu-
gation at 25,000 rpm at 22°C for 2 h in a SW40 Ti Beckman rotor. Virus bands
were removed with a syringe and dialyzed against 4  1-liter volumes of 10 mM
Tris-HCl, pH 7, at 4°C. To remove any contaminating RNA associated with the
outside of the virus particles, the concentrate was incubated with RNAseA (final
concentration, 50 g ml1) for 1 h at 37°C and treated with Proteinase K (final
concentration, 50 g ml1) and sodium dodecyl sulfate (SDS) (final concentra-
tion, 0.5%), and the samples were incubated at 60°C for 1 h. Samples were then
treated to extract total RNA as described previously. Purified total RNA was
then treated with RNase free DNase (QIAGEN) in a 50 l volume. Following
DNase treatment, RNA was cleaned and purified, using the Roche Target
Purification kit (Roche), and eluted in 50 l RNase-free water and stored at
80°C. RNA quantity and quality were assessed using the Agilent Bioanalyzer
2100 system. All RNA samples were checked for virus genomic DNA contami-
nation by PCR, using virus major-capsid protein gene primers (14). All samples
tested negative for viral genomic DNA contamination.
Fluorescent labeling of cRNA. Random amplification of the entire mRNA
population was achieved using the Microarray Target Amplification kit (Roche).
This requires the use of a special primer containing a random sequence with no
significant homology to any known sequences in public databases (Target Am-
plification Sequence [TAS]) in addition to a T7 promoter and oligo(dT) se-
quences for first-strand cDNA synthesis. The TAS region generates a 3 anchor
on the cDNA for subsequent PCR amplification with a TAS-PCR primer. First-
and second-strand cDNA synthesis was performed from 200 ng of template RNA
and 10 pg of spike mRNA (Stratagene), and the product was purified using the
Target Purification kit (Roche). Purified cDNA was then randomly amplified by
24 cycles of PCR with TAS primers. PCR products were purified using the
Microarray Target Purification kit (Roche) and then concentrated using YM30
Microcon concentration columns (Millipore). The resulting PCR-amplified
cDNA was then transcribed into Cy3 fluorescently labeled cRNA, using the T7
Microarray RNA Target Synthesis kit (Roche). Labeled cRNA was then purified
using the Microarray Target Purification kit. The EhV-86 microarray has been
described previously (22). Briefly, 75-mer oligonucleotides are spotted in tripli-
cate for 425 of the 472 predicted CDSs of EhV-86. For hybridization to microar-
rays, 7.5 l 20  SSC (Sigma), 1.0 l 10% SDS, and the labeled cRNA sample
were combined in a total volume of 50 l. After being incubated at 100°C for 2
min (lid temperature, 110°C), the samples were cooled (room temperature, 5
min) and the volume was checked (and made up to 50 l when necessary) prior
to loading the samples onto the microarray slide covered by a LifterSlip (Erie
Scientific Company). Microarray hybridization was performed in a microarray
hybrid chamber (Camlab) at 65°C for 18 h. The microarray slides were given
three posthybridization washes. The first wash was in 50 ml of 1  SSC–0.1%
SDS for 5 min with constant agitation, followed by a second wash for a further
5 min (with constant agitation) in 50 ml of 0.1  SSC–0.1% SDS. A third wash
was performed by plunging the slides 20 times into 50 ml of 0.1  SSC. The
microarray slides were immediately centrifuged to remove residual liquid (200 g,
1 min) and stored in the dark prior to being scanned. Three biologically inde-
pendent samples for each of the four main study conditions (uninfected Emil-
iania huxleyi, postinfection at 0 h, 1 h, 2 h, and 4 h) were hybridized to one array
each. For validation purposes, three further arrays were hybridized with RNA
extracted from purified EhV-86 virion particles, and one array was hybridized
with just the Stratagene spike RNA.
Microarray data processing and analysis. (i) Scanning and image processing.
Hybridized arrays were scanned with an Affymetrix 418 array scanner. Six scans
at incremental settings (gains of 0, 5, 10, 15, 20, and 25) were performed for each
array in order to determine and select the optimal scan setting, producing a high
dynamic signal range without saturation (9). Images from all scans were quan-
tified using GMS Scanner software, version 1.51.0.42, and ImaGene, version
5.6.1.
All subsequent data processing and analysis steps were carried out with the R
version 2.1.1 statistical programming environment (www.r-project.org) and Bio-
conductor version 1.6 microarray modules (www.bioconductor.org).
(ii) Background correction. Assessment of global noise and signal distributions
showed evidence for a background noise gradient across some arrays. The effect
was only noticeable at very low fluorescence levels and had no corresponding
visible effect on signal levels. A log-linear interpolation method (Edwards) was
used to correct lower-intensity values for any background carryover effects (8).
(iii) Normalization. A targeted viral array is likely to violate the assumptions
that are made before applying global normalization methods; in this case it can
be expected that 10% or more of the probes on the array will change expression
levels between different biological conditions or time points. In anticipation of
this, a large set of positive-control probes were included on the array (10 Strata-
gene alien probes, printed in triplicate on each of the 16 subgrids). The chosen
normalization method was scaling of subset (n 	 480 probes) medians to a
common reference value, after an initial log2 transformation of all data values.
(iv) Expression determination. Expressed and/or not expressed calls for each
gene and time point were generated on the basis of a detection threshold
determined by the ninetieth percentile value of negative-control probes. A probe
with an intensity value above this threshold was considered to be “on.”
(v) Differential expression and hypothesis testing. Prior to further analysis, a
nonspecific filter was applied to remove biologically irrelevant genes (control
probes). This process reduces problems with statistical testing on multiple vari-
ables simultaneously. Of a total of 2,496 probes, 1,440 remained in the analysis
set. The threshold for the filtering was in this case based on the slightly less
stringent eightieth percentile of negative-control probe intensities. Differential
expression was determined in two ways: (i) from an uninfected baseline sample
to each of the postinfection time points and (ii) between postinfection time
points. A statistical test with relative robustness for small sample sizes (simple
linear model enhanced by empirical Bayes) was used to test the null hypothesis
of nondifferential expression for each individual gene. Simultaneous testing on
large numbers of variables (genes) leads to an increased number of potentially
false-positive results; a Benjamini and Hochberg P-value correction was there-
fore applied.
(vi) Explorative analysis. Prior to explorative analysis, a further nonspecific
filter was applied to remove genes which were not “on” in at least 3 out of 18
arrays, reducing the number of probes to 1,288. Absolute expression data were
grouped and visualized using a hierarchical biclustering algorithm on expression
profiles of genes and samples, combined with a heat map. The clustering param-
eters were “1 minus correlation” as the distance measure and “average” as the
linkage method. The gene clusters were standardized to have means and stan-
dard deviations of 0 and 1, respectively, across arrays.
Microarray data accession number. Microarray data (including microarray
design, hybridization, and analysis) were stored and curated in maxdLoad2 prior
to submission in MAGE/ML format to the EBI Array Express database (http:
//www.ebi.ac.uk/arrayexpress) under accession number E-MAXD-8 (10). This
data is also available at the EGTDC data catalog (http://envgen.nox.ac.uk/)
under accession number egcat:000010.
RESULTS AND DISCUSSION
Characterization of temporal expression profile. By random
amplification of mRNA extracted from infected cells and using
microarrays, the expression profile of the EhV-86 infection of
E. huxleyi was determined over the first 4 h of infection (see
Table S1 in the supplemental material). RNA samples were
extracted at 0, 1, 2, and 4 h postinfection. CDSs were catego-
rized into group T1, T2, or T4, based upon whether their
expression was first detected at 1, 2, or 4 h postinfection,
respectively (Fig. 1). Thirty-nine CDSs were assigned to group
T1, 194 CDSs to group T2, and 71 CDSs to group T4. Tran-
scripts for a further 115 were not detected, including 51 that
have previously been detected in the 33-h-postinfection lytic-
phase transcriptional profile (22), suggesting that the virus
infection cycle may not be fully completed at 4 h postinfection.
However, the transcript for the major capsid protein gene,
ehv085, was detected at 4 h postinfection, suggesting that, at
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this point, the virus is in the latter stages of the infection
process.
Early transcripts. During the preliminary annotation of the
EhV-86 genome, CDSs were numbered sequentially, starting
with ehv001 (bases 276 to 1,022) through to ehv468 (bases
406,039 to 406,896). The subsequent addition of any extra
CDSs was achieved by naming according to the nearest CDS
and adding an “A” suffix (e.g., ehv185A). Hence, the CDS
number indicates the genomic location of a CDS relative to the
neighboring CDSs. The 39 T1 virus transcripts are all localized
to a specific region of the EhV-86 genome and have CDS
numbers ranging between 218 and 366 (Fig. 1). These CDSs
are found in a 104-kb section of the genome that has previously
been identified as containing unique putative promoter ele-
ments known as family A repeats (3). The 151 CDSs in this
region have few database homologues, and their origin and
function are completely unknown (2, 3). Family A repeats are
characterized by the presence of the conserved nonamer GT
TCCC(T/C)AA that is found directly upstream of the pre-
dicted start of translation methionine codon (ATG) for 87 of
the CDSs in this region. Expression of 39 CDSs from this
region (P values 
 0.01) at only 1 h postinfection, in combi-
nation with no expression from CDSs outside of this region, is
a significant finding (Fig. 1; see also Table S2 in the supple-
mental material for P values).
Genes in the 104-kb central region not associated with the
putative promoter show a different absolute expression profile
to those associated with the putative promoter (Fig. 2). Two
FIG. 1. Grouping of EhV-86 CDSs. EhV-86 CDSs are listed at the experimental time point at which they first show statistically significant
(P
 0.01) differential expression compared to that of baseline uninfected samples (T1, T2, and T4 indicate 1, 2, and 4 h postinfection, respectively).
CDSs are included in this table only if they match two criteria. The first criterion requires CDSs to have signal intensity values above the detection
threshold for at least two out of three print replicates (asterisks indicate two probe replicates in agreement). The detection threshold is defined
nonparametrically as the ninetieth percentile of human negative-control probes. The second criterion requires the differential expression compared
to that of uninfected samples to be statistically significant for all three print replicates of a CDS.
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apparently non-promoter-associated CDSs can be seen to clus-
ter with the promoter-associated CDSs; these correspond to
ehv349, which encodes a putative protease. This CDS is asso-
ciated with the promoter element but was grouped with the
proteases for the purpose of this analysis. The three replicate
probes for ehv247 (which is not directly associated with the
promoter) can be seen to cluster with the promoter-associated
CDSs. It is likely that this CDS is cotranscribed with the im-
mediately adjacent ehv248, which does have the promoter.
Those associated with the putative promoter have the high-
est expression levels at 1 h postinfection, whereas the CDSs in
this region not associated with the putative promoter show
similar expression profiles to those from the remainder of the
genome. This early expression pattern provides important new
evidence that family A repeats do function as promoter ele-
ments. Indeed, it has previously been suggested that family A
repeats may function as immediate-early promoters (2, 3, 22).
Expression driven by these promoter elements is likely to play
an integral role during the early stages of the virus infection
process. However, the lack of database homologues for the
CDSs putatively driven by these promoters reveals no obvious
insights into the function of this group of genes. Their early
expression suggests that they could perform a regulatory role
akin to the immediate-early genes identified in other viruses (4,
7, 16). Future functional analysis of this region will provide
vital clues to the life cycle of this virus and the unique role of
this 104-kb region.
Unexpectedly, expression of RNA polymerase subunit genes
(ehv064, ehv108, ehv167, ehv399, and ehv434) does not appear
to occur until later on in the infection process (transcripts for
RNA polymerase subunits are first detected at 2 h postinfec-
tion) (Fig. 1), suggesting that the host RNA polymerase is
responsible for expression of T1 genes or that the virus pack-
ages its own RNA polymerase into the virion.
Differential expression. An explorative analysis using biclus-
tering and heat map visualization of absolute expression values
(Fig. 3) reveals that the uninfected transcriptional profile (Tu)
is, as would be expected, very similar to the infected profile
immediately after infection (T0), with only a handful of host
genes expressed on the array. Host genes display a general
trend of down regulation (although this down regulation is not
statistically significant) which accounts for the minor differ-
ences between the Tu and T0 profiles. These changes are likely
to have been caused by the unavoidable delay between sam-
pling cells and freezing of the RNA profile (approximately 5
min), indicating that the virus may have an effect on the host
cell within minutes of infection. Two-hour and 4 h postinfec-
tion transcriptional profiles (T2 and T4, respectively) are very
similar and cluster tightly together with transcripts for the
majority of EhV-86 CDSs expressed (Fig. 1 to 3). The 1 h
postinfection transcriptional profile (T1) fails to associate
closely with either of these two clusters but appears closer to
the Tu and T0 profiles than to T2 and T4 (Fig. 3).
The similarity in profiles between Tu and T0 and between T2
A B
C D
FIG. 2. Scatterplots of absolute CDS expression for uninfected versus each of the infected samples. The center diagonal lines represent “no
difference in expression,” and the two diagonal lines parallel to the center line represent the threshold for twofold-up and twofold-down regulation.
The rectangular box outlined with a dashed line indicates the detection threshold for each of the two biological conditions; i.e., probes inside this
box are not expressed or not measurable in uninfected and infected samples. The three replicate values for each CDS are shown.
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and T4 is represented by the linear distribution observed in Fig.
2A and D. Viral transcripts are expressed at increasing levels
for the first 2 h of infection (Fig. 2B and C), after which the
expression levels of the majority of CDSs are maintained at a
more consistent level.
Virion message. When a target was labeled from a total
RNA extraction performed on purified EhV-86 virions as a
control, the only transcript detected above threshold levels on
the microarray was that of ehv315 (P value 
 0.01) (data not
shown). CDS ehv315 is a proline-rich putative membrane pro-
tein of unknown function (22). Proline-rich proteins have pre-
viously been implicated in calcium binding (22), which is of
particular interest since the host, E. huxleyi, is well known for
the sequestration of calcium carbonate onto its surface (in the
form of coccoliths) during active growth (21). Whether the
protein EHV315 plays a role in disrupting this pathway is yet
to be determined but clearly warrants further investigation.
CDSs not expressed. Many of the EhV-86 CDSs where no
transcript was detected at 4 h postinfection have been assigned
a putative function (22) (Fig. 4). Noteworthy is the lack of
detection of transcripts for five of the eight proteases predicted
to be encoded in the EhV-86 genome (ehv021, ehv109, ehv160,
ehv349, and ehv361) (22). Virally encoded proteases have pre-
viously been shown to be involved in the maturation of infec-
tious virions, suggesting further that at 4 h postinfection the
full virus replication cycle may not yet have been completed
(15). At 4 h postinfection, the cell has only just started releas-
ing virus particles and we know it continues to release viruses
for up to 2 days while remaining intact (data not shown). This
leaves scope for a range of new transcripts to be up-regulated
FIG. 3. Biclustering of CDS and sample expression profiles in combination with heat map visualization. Each column represents the averaged
log2 expression data for three independent samples for a biological condition. Each row in the heat map represents one CDS color coded for
expression level from low (blue) to medium (white) to high (red). Branches on the top and side of the heat map show the identified clusters in
the sample, i.e., samples with the most-similar expression profiles across all genes and genes with similar expression profiles across all samples. As
expected, results for uninfected (Tu) samples and samples at 0 h postinfection (T0) are very closely related. The later time points T2 and T4 are
also closely related. T1 is the most interesting, showing a cluster of CDSs which go from “off” in the Tu and T0 samples to “on.”
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at specific time points after this initial 4-h period. Moreover,
the EhV-86 genome also encodes key components of sphingo-
lipid biosynthesis, a pathway that leads to the production of
ceramide (22), and these genes are expressed at 2 h postinfec-
tion (Fig. 1). It is known that there is a connection between
protease activation and ceramide-induced apoptosis (17). A
virus-controlled apoptotic mechanism is unlikely to induce cell
death in the early stages of infection; consequently, protease
expression will most likely be up-regulated closer to the onset
of apoptosis and cell disintegration, up to 2 days later.
Other transcripts notable for their lack of detectable tran-
scription include those coding for a putative lectin protein
(ehv060), DNA-binding proteins (ehv072 and ehv152), phos-
phate permease (ehv117), thioredoxin (ehv358), protein kinase
(ehv402), esterase (ehv363), fatty acid desaturase (ehv415),
and a topoisomerase (ehv444). Indeed, for a number of CDSs
transcripts have not been detected in the previous lytic-phase
transcriptional profile (generated 33 h postinfection) or during
the work described here (Fig. 4) (22). Four of these are “core
genes” (ehv072, ehv128, ehv166, and ehv444) previously iden-
tified as being conserved in the nuclear-cytoplasmic large DNA
virus (NCLDV) family. Their high degree of conservation in
this family would suggest a role crucial to the virus, and with
such a role they would be expected to be expressed. The lack
of detection of these transcripts could be caused by their lack
of expression or their expression at levels too low to be de-
tected. Future work involving real-time PCR may determine
whether these CDSs are expressed and at what levels.
Closing discussion. The infection cycle of EhV-86 can be
divided into two broad stages: a primary stage in which a
distinctive subgroup of localized CDSs associated with a puta-
tive promoter element are transcribed and a secondary stage
during which CDSs are transcribed regardless of their genomic
location. The function of the primary stage is difficult to ascer-
tain, since the vast majority of the CDSs expressed have little
or no database homologues. CDSs from this region have been
shown to have some of the highest levels of expression during
the infection process (22), presumably due to their early and
then constant high levels of expression, suggesting that they are
of vital importance to the infection strategy.
The presence of RNA polymerase genes in the EhV-86
genome implies that the virus has the capacity to transcribe its
own genes from within the cytoplasm during infection. It is not
implausible to suggest that the biphasic stages of expression
that occur during EhV-86 infection of E. huxleyi are compart-
mentalized. There is no evidence that transcription of virus
RNA polymerase genes occurs until at least 1 h into the infec-
tion; therefore, there are two main possibilities that could
account for the expression of the primary genes: (i) a func-
tional viral RNA polymerase that recognizes family A promot-
ers is packaged into the mature virion and causes expression of
primary CDSs in the cytoplasm, or (ii) following infection, viral
DNA targets the host nucleus where host RNA polymerase
recognizes family A promoters, leading to transcription of pri-
mary genes. Targeting of virus genomic DNA to the nucleus
has previously been suggested to occur during the infection of
FIG. 4. EhV-86 CDSs for which expression of the transcript could not be detected above threshold levels, confirmed, or tested. CDSs that have
previously been detected in a 33-h postinfection lytic-phase transcriptional profile are in bold (22). A transcript is defined as “not detected” if at
least two out of three print replicates for this gene have signal intensity values at or below the ninetieth percentile for the signal intensity value
of human negative-control probes.
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Chlorella by PBCV-1 (18). The change from nuclear to cyto-
plasmic intracellular compartments (or vice versa) could ac-
count for the distinctive change in transcriptional profile ob-
served in these experiments. If promoters similar to the family
A repeats are identified during the genomic sequencing of E.
huxleyi (currently under way), the second option above should
certainly gain greater credence. If this is the case, subsequent
breakdown of host genomic DNA (ehv041 encodes an endo-
nuclease and is expressed between 1 and 2 h postinfection) and
the nuclear envelope (a viral protease, encoded by ehv349, is
expressed during the first hour of infection) could initiate the
secondary stage of infection, where the remaining virus genes
are expressed.
The presence of RNA polymerase in the EhV-86 genome, so
far unique among the Phycodnaviridae, suggested a unique
replication cycle for this giant virus. The virally encoded RNA
polymerase may be intrinsically linked to the virus-encoded
sphingolipid biosynthesis pathway (22). Sphingolipids are well
documented as playing a crucial role in controlling cell death
(12). If degradation of host DNA does occur during infection,
then the ability to make new host-encoded RNA polymerase
would be lost. Furthermore, if cell death is delayed extensively
by the manipulation of sphingolipid biosynthesis, the active pro-
duction of a virus-encoded RNA polymerase during the pro-
longed infection would prove vital to the replication strategy of
the virus. Consequently, this could account for the retention of
RNA polymerase function in coccolithoviruses (2).
The NCLDV group is composed of the Asfariviridae, Pox-
viridae, Mimiviridae, Iridoviridae, and Phycodnaviridae families
(2). These diverse families are likely to have shared a common
ancestor which was likely to have had both nuclear and cyto-
plasmic phases in its life cycle (11). Lineage-specific gene loss
and gain within the NCLDV families is thought to contribute
to the highly diverse characteristics of present-day forms. Pox-
viruses, asfarviruses, and iridoviruses encode their own tran-
scription and replication machinery and undergo their replica-
tion cycles entirely in the cytoplasm (poxviruses) or start it in
the nucleus and complete it in the cytoplasm (asfariviruses and
iridoviruses) (11). Prior to the sequencing of EhV-86, the phy-
codnaviruses were thought to be characterized by their nuclear-
dependent replication cycles. This interesting coccolithovirus
appears to have a replication cycle more similar to that of
the ancestral virus, a cycle distinct from all currently known
Phycodnaviridae.
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